| Symbol | TRIB |
|---|---|
| Name | TRINITY BIOTECH PLC |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Address | IDA BUSINESS PARK,BRAY, CO. WICKLOW, DUBLIN, Ireland |
| Telephone | +353 12769800 |
| Fax | — |
| — | |
| Website | https://www.trinitybiotech.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000888721 |
| Description | Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Ireland of which it derives a majority of its revenues from the Americas segment. Additional info from NASDAQ: |
Trinity Biotech Secures Additional $7.0 Million Investment from Perceptive Advisors and Regains Compliance with Nasdaq Minimum Bid Price Requirement
Read moreTrinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology
Read moreNew Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring
Read moreTrinity Biotech’s Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling
Read moreTrinity Biotech Terminates Standby Equity Purchase Agreement with Yorkville
Read moreTrinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market
Read moreNew Form 424B3 - TRINITY BIOTECH PLC <b>Filed:</b> 2026-06-23 <b>AccNo:</b> 0001554855-26-001392 <b>Size:</b> 78 KB
Read moreTrinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results
Read moreNew Form 424B3 - TRINITY BIOTECH PLC <b>Filed:</b> 2026-06-15 <b>AccNo:</b> 0001554855-26-001334 <b>Size:</b> 213 KB
Read more